First Patient Treated in New Multiple Myeloma Trial Using Advanced Cell Therapy
A new clinical trial has started for patients with multiple myeloma, a type of blood cancer, that no longer responds […]
New Drug Receives Special FDA Status to Help Liver Regenerate After Surgery
A new experimental drug called darizmetinib, developed by a company called HepaRegeniX, has received a special designation from the U.S.
Pharmaceutical News
Roche’s Genentech Expands Drug Manufacturing in Oregon with $750 Million Investment
Roche’s Genentech division is expanding its drug manufacturing operations in Hillsboro, Oregon, by investing approximately $750 million to double the
Weekly Update: New Drug Pricing Deals, Breakthroughs in Gene Therapy, and Major Pharma Deals
This week in pharmaceutical news brings important updates that could impact patients and healthcare providers. Here’s a breakdown in simple
New FDA-Approved Treatment for a Rare Blood Disorder: What You Need to Know
The U.S. Food and Drug Administration (FDA) has just approved a new medication called IMAAVY for a condition called warm
Pharmaceutical News
Major Global Shift in Medicine Regulations Could Speed Up Drug Production and Reduce Animal Use
A new international pilot program is changing how global regulators and pharmaceutical companies manage changes to approved medicines after they
Pharmaceutical News
New Obesity Treatment in Development: A First-of-Its-Kind Approach from Genentech and Hanmi Pharm
A potential new treatment for obesity, called HM17321, is being developed by Genentech (a part of the Roche Group) and
FDA Approves First HIV Treatment for Newborns Weighing Just 2 kg
ViiV Healthcare has received approval from the U.S. Food and Drug Administration (FDA) for a new version of the HIV
Pharmaceutical News
New EU-Approved Medicine for Rett Syndrome Offers Hope for Children and Families
A new medication called Daybu (trofinetide) has been approved in Europe for children aged five and older who have Rett
New Alzheimer’s Treatment Available in a Convenient Once-Weekly Injection
Eisai and Biogen have introduced a new form of the Alzheimer’s medication Leqembi called Leqembi Iqlik. This version comes as